Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis

被引:16
作者
Distler, O. [1 ]
Behrens, F.
Huscher, D.
Foeldvari, I.
Zink, A.
Nash, P.
Denton, C. P.
Humbert, M.
Matucci-Cerinic, M.
Seibold, J.
Rubin, L.
Furst, D. E.
机构
[1] Univ Zurich Hosp, Dept Rheumatol, CH-8091 Zurich, Switzerland
[2] Goethe Univ Frankfurt, ZAFES, Div Rheumatol, D-6000 Frankfurt, Germany
[3] German Rheumatism Res Ctr, Berlin, Germany
[4] Rheumatol Res Unit, Sunshine Coast, Qld, Australia
[5] UCL Royal Free & Univ Coll, Sch Med, Ctr Rheumatol, London, England
[6] Univ Paris Sud, Hop Antoine Beclere, Ctr Malad Vasc Pulm, Serv Pneumol & Reanimat Resp, Clamart, France
[7] Univ Terapia Med I, Florence, Italy
[8] Univ Michigan, Scleroderma Program, Ann Arbor, MI 48109 USA
[9] Univ Calif San Diego, Sch Med, Div Pulm & Crit Care Med, La Jolla, CA 92093 USA
[10] Univ Calif Los Angeles, David Geffen Sch, Dept Med, Div Rheumatol, Los Angeles, CA USA
关键词
D O I
10.1093/rheumatology/kel273
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1455 / 1457
页数:3
相关论文
共 25 条
[1]   Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial [J].
Badesch, DB ;
Tapson, VF ;
McGoon, MD ;
Brundage, BH ;
Rubin, LJ ;
Wigley, FM ;
Rich, S ;
Barst, RJ ;
Barrett, PS ;
Kral, KM ;
Jöbsis, MM ;
Loyd, JE ;
Murali, S ;
Frost, A ;
Girgis, R ;
Bourge, RC ;
Ralph, DD ;
Elliott, CG ;
Hill, NS ;
Langleben, D ;
Schilz, RJ ;
McLaughlin, VV ;
Robbins, IM ;
Groves, BM ;
Shapiro, S ;
Medsger, TA ;
Gaine, SP ;
Horn, E ;
Decker, JC ;
Knobil, K .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :425-+
[2]   Sitaxsentan therapy for pulmonary arterial hypertension [J].
Barst, RJ ;
Langleben, D ;
Frost, A ;
Horn, EM ;
Oudiz, R ;
Shapiro, S ;
McLaughlin, V ;
Hill, N ;
Tapson, VF ;
Robbins, IM ;
Zwicke, D ;
Duncan, B ;
Dixon, RAF ;
Frumkin, LR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (04) :441-447
[3]   Beraprost therapy for pulmonary arterial hypertension [J].
Barst, RJ ;
McGoon, M ;
McLaughlin, V ;
Tapson, V ;
Oudiz, R ;
Shapiro, S ;
Robbins, IM ;
Channick, R ;
Badesch, D ;
Rayburn, BK ;
Flinchbaugh, R ;
Sigman, J ;
Arneson, C ;
Jeffs, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2119-2125
[4]  
Bellamy N, 1999, J RHEUMATOL, V26, P948
[5]  
Boers M, 1998, J RHEUMATOL, V25, P198
[6]  
Channick R., 2001, Journal of Heart and Lung Transplantation, V20, P262, DOI 10.1016/S1053-2498(00)00606-9
[7]   Ambrisentan therapy for pulmonary arterial hypertension [J].
Galié, N ;
Badesch, D ;
Oudiz, R ;
Simonneau, G ;
McGoon, MD ;
Keogh, AM ;
Frost, AE ;
Zwicke, D ;
Naeije, R ;
Shapiro, S ;
Olschewski, H ;
Rubin, LJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (03) :529-535
[8]   Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension [J].
Galiè, N ;
Seeger, W ;
Naeije, R ;
Simonneau, G ;
Rubin, LJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :81S-88S
[9]   Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension:: With pulmonary arterial hypertension:: A randomized, double-blind, placebo-controlled trial [J].
Galiè, N ;
Humbert, M ;
Vachiéry, JL ;
Vizza, CD ;
Kneussl, M ;
Manes, A ;
Sitbon, O ;
Torbicki, A ;
Delcroix, M ;
Naeije, R ;
Hoeper, M ;
Chaouat, A ;
Morand, S ;
Besse, B ;
Simonneau, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (09) :1496-1502
[10]   Sildenafil citrate therapy for pulmonary arterial hypertension [J].
Galiè, N ;
Ghofrani, HA ;
Torbicki, A ;
Barst, RJ ;
Rubin, LJ ;
Badesch, D ;
Fleming, T ;
Parpia, T ;
Burgess, G ;
Branzi, A ;
Grimminger, F ;
Kurzyna, M ;
Simonneau, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2148-2157